AARDVARK THERAPEUTICS, INC. Proceeds from Common Stock Issued
AARDVARK THERAPEUTICS, INC. (AARD) reported Proceeds from Common Stock Issued of $259.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-11
- AARDVARK THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2025 was $195.00K.
- AARDVARK THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2024 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $259.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $195.00K 10-K · filed 2026-03-23 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |